- CUSIP
- 74016W841
- Issuer
- Precidian
- Inception Date
- Jan 2, 2025
- Category
- Foreign Large Cap Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mega-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $4M
Highlights
- Avg. Volume (1M)
- 2K
- Avg. Volume Value (1M)
- $41.70K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NVOH Performance Chart
Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) is down 3.1% since the beginning of the year. NVOH is currently trading at $25 per share.
Loading charts...
Compare this symbol against anything
Returns By Period
Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) has returned -3.13% so far this year and 2.68% over the past 12 months.
Novo Nordisk A/S (B Shares) ADRhedged ETF
- 1D
- -8.23%
- 1M
- -7.20%
- 6M
- -15.76%
- YTD
- -3.13%
- 1Y
- 2.68%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -32.27%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
NVOH Monthly Returns History
Based on dividend-adjusted daily data since Jan 7, 2025, NVOH's average daily return is -0.11%, while the average monthly return is -2.00%.
Historically, 47% of months were positive and 53% were negative. The best month was Aug 2025 with a return of +17.4%, while the worst month was Feb 2026 at -36.1%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.
On a daily basis, NVOH closed higher 47% of trading days. The best single day was Feb 6, 2026 with a return of +9.4%, while the worst single day was Jul 29, 2025 at -20.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.99% | -36.05% | 3.36% | 12.61% | 8.27% | 7.21% | -2.50% | -3.13% | |||||
| 2025 | -0.30% | 7.12% | -24.98% | -8.58% | 7.13% | -6.77% | -28.29% | 17.41% | -1.68% | -9.00% | -0.36% | 2.38% | -43.79% |
Benchmark Metrics
Novo Nordisk A/S (B Shares) ADRhedged ETF has an annualized alpha of -34.27%, beta of 0.92, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since January 07, 2025.
- This ETF participated in 301.87% of S&P 500 Index downside but only 10.13% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -34.27%
- Beta
- 0.92
- R²
- 0.11
- Upside Capture
- 10.13%
- Downside Capture
- 301.87%
Expense Ratio
NVOH has an expense ratio of 0.19%, which is considered low.
Return for Risk
Risk / Return Rank
NVOH ranks 14 for risk / return — above 14% of ETFs peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVOH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.33 | ||
| Sortino ratioReturn per unit of downside risk | -1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.25 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 0.09 | 2.00 | -1.91 |
| Martin ratioReturn relative to average drawdown | 0.17 | 8.49 | -8.32 |
Dividends
Dividend History
Novo Nordisk A/S (B Shares) ADRhedged ETF provided a 6.67% dividend yield over the last twelve months, with an annual payout of $1.70 per share.
| Period | TTM | 2025 |
|---|---|---|
| Dividend | $1.70 | $0.65 |
Dividend yield | 6.67% | 2.38% |
Monthly Dividends
The table displays the monthly dividend distributions for Novo Nordisk A/S (B Shares) ADRhedged ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.77 | $0.00 | $1.04 | |||||
| 2025 | $0.17 | $0.00 | $0.00 | $0.49 | $0.65 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Novo Nordisk A/S (B Shares) ADRhedged ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Novo Nordisk A/S (B Shares) ADRhedged ETF was 61.60%, occurring on Mar 27, 2026. The portfolio has not yet recovered.
The current Novo Nordisk A/S (B Shares) ADRhedged ETF drawdown is 49.02%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-61.60%Mar 2026 | 1y 24d | — | 1y 5moMar 2025 - now | — |
-11.28%Feb 2025 | 1mo 2d | 10d | 1mo 12dJan 2025 - Feb 2025 | 2025 selloff2025 |
-1.42%Jan 2025 | 1d | 1d | 1dJan 2025 - Jan 2025 | — |
-1.12%Feb 2025 | 1d | 2d | 3dFeb 2025 - Feb 2025 | 2025 selloff2025 |
Drawdown Indicators
| NVOH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.60% | -56.78% | -4.82% |
Max Drawdown (1Y)Largest decline over 1 year | -40.93% | -9.10% | -31.83% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -49.02% | -1.58% | -47.44% |
Average DrawdownAverage peak-to-trough decline | -39.23% | -10.70% | -28.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.49% | 2.14% | +20.35% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with NVOH
Add Novo Nordisk A/S (B Shares) ADRhedged ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NVOH